BlinkLab (ASX:BB1) to participate in a clinical study on early diagnosis of dementia in partnership with Erasmus University Medical Center
By API User
Sydney, NSW — BlinkLab Limited (ASX:BB1), a pioneering digital healthcare company specializing in AI-driven diagnostics for neurological disorders, is thrilled to announce its participation in a transformative clinical study led by Erasmus University Medical Center (Erasmus MC) in Rotterdam. This collaboration aims to enhance the early and accurate diagnosis of dementia, specifically frontotemporal dementia (FTD) … Continued